VCYT

Veracyte
VCYT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.38B
EV
$2.11B
Shares Outstanding
79.65M
Beta
1.97

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$39.75
P/E 2025E
21.37x
P/Revenue 2025E
4.76x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Veracyte, Inc.

gainify
VCYT

Veracyte, Inc.

VCYT

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna...

Sector

Healthcare

Industry

Biotechnology

CEO

Stapley, Marc

Employees

824

IPO Date

2013-10-30

Headquarters

6000 Shoreline Court, Suite 300, South San Francisco, California, 94080, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.